122 related articles for article (PubMed ID: 8103762)
1. Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells.
Rakhmilevich AL; North RJ; Dye ES
Int J Cancer; 1993 Sep; 55(2):338-43. PubMed ID: 8103762
[TBL] [Abstract][Full Text] [Related]
2. Generation of specific antitumor cytotoxic T-lymphocytes in monoculture can be inhibited by T-suppressors from tumor-bearing mice.
Lupatov AYu ; Brondz BD
Cancer Biother; 1994; 9(2):123-9. PubMed ID: 7812361
[TBL] [Abstract][Full Text] [Related]
3. Effect of graft-versus-host disease on anti-tumor immunity.
Schreiber KL; Forman J
J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
[TBL] [Abstract][Full Text] [Related]
4. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
[TBL] [Abstract][Full Text] [Related]
5. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
Dye ES; North RJ
J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
[TBL] [Abstract][Full Text] [Related]
7. The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.
Walker PR; Calzascia T; Schnuriger V; Scamuffa N; Saas P; de Tribolet N; Dietrich PY
J Immunol; 2000 Sep; 165(6):3128-35. PubMed ID: 10975826
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific CD4(+) suppressor T-cell clone capable of inhibiting rejection of syngeneic sarcoma in A/J mice.
Fu T; Shen Y; Fujimoto S
Int J Cancer; 2000 Sep; 87(5):680-7. PubMed ID: 10925362
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
10. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
12. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
Awwad M; North RJ
J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
[TBL] [Abstract][Full Text] [Related]
13. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
14. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
15. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
16. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
Prell RA; Kerkvliet NI
J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes.
Lynch DH; Namen AE; Miller RE
Eur J Immunol; 1991 Dec; 21(12):2977-85. PubMed ID: 1684156
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity.
Noël C; Florquin S; Goldman M; Braun MY
Int Immunol; 2001 Apr; 13(4):431-9. PubMed ID: 11282982
[TBL] [Abstract][Full Text] [Related]
19. Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma.
North RJ; Awwad M
Immunology; 1990 Sep; 71(1):90-5. PubMed ID: 2145216
[TBL] [Abstract][Full Text] [Related]
20. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
Cassell D; Forman J
J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
